Objective: To analyze the outcome after surgery for critical limb ischemia (CLI) due to tibial artery occlusion in patients with systemic scleroderma. Methods: The medical records of scleroderma patients with CLI due to tibial artery occlusion were reviewed with respect to demographic data and perioperative variables. Results: Eight patients were identified at The University of Tokyo Hospital from 1991 to 2007. The underlying collagen disease was progressive systemic scleroderma in 6 patients and CREST syndrome in 2 patients. The subjects were 1 man and 7 women with a mean age of 68 years. While hypercoagulability including positive anticardiolipin antibodies was found in only 1 patient, all patients were antinuclear antibody (ANA) positive and 6 of 8 patients had a high titer of centromere-type ANA. Five underwent pedal artery bypass and 1 underwent distal peroneal artery bypass, while 2 underwent primary limb amputation. Although 1 patient with bypass had early graft occlusion (with subsequent below-knee amputation), the other 5 patients with patent grafts quickly achieved pain relief and initial wound healing. However, four of the five patent grafts developed graft occlusion several months after surgery, with severe intimal thickening at the anastomosis. As a result, 2 of 6 patients with bypass (totally 4 of 8 patients) underwent limb loss and 1 patient developed persistent recurrent ulcer. Conclusion: Bypass surgery in patients with scleroderma and CLI can be successful in achieving early pain relief and ischemic wound healing. However, the long-term effectiveness is limited with high rates of graft failure and limb loss. ( J Vasc Surg 2009;49:918-23.)
While Raynaud's phenomenon is the most common vascular manifestation, digital ischemia is a predominant complication of systemic scleroderma. Severely affected patients develop vasculitis and/or thrombosis leading to occlusion of digital arteries, and digital ulceration or gangrene resulting in autoamputation of the digits. Reidy et al 1 reported that only 7 of 1030 patients with scleroderma developed non-healing ulcers which progressed in severity to require lower limb amputation, while Hasegawa et al 2 reported that arteriography could identify stenosis or occlusion of tibial arteries at some rate of patients with scleroderma and digital ulceration. Obliteration of these vessels worsens ischemia and leads to critical limb ischemia (CLI) of the lower extremity. 3, 4 Although a lesion of the infrapopliteal arteries in scleroderma can lead to major leg amputation, there have been few reports on the management of CLI, including revascularization. The present study describes systemic scleroderma patients with CLI who underwent pedal bypass surgery and discusses the indication for bypass surgery in those patients.
MATERIALS AND METHODS
This study reports a series of 8 patients (6 patients with progressive systemic scleroderma [PSS] and 2 with its limited type CREST syndrome) who had CLI due to diffuse infrapopliteal arterial occlusion, at the University of Tokyo Hospital from 1991 to 2007.
Every patient enrolled in the study met the criteria for scleroderma established by the American Rheumatism Association. Their medical records were checked and laboratory tests were carried out. Immune serological tests comprised antiphospholipid antibody, antineutrophil cytoplasmic antibody (ANCA, p-ANCA: perinuclear ANCA, c-ANCA: cytoplasmic ANCA), and antinuclear antibody (ANA). Measurement of skin perfusion pressure by laser Doppler was described previously. 5 The tibial arteries are defined as infrapopliteal arteries including the anterior and posterior tibial arteries, peroneal artery, and their branches.
Patients underwent preoperative angiography to determine the precise targeted artery before bypass surgery. The operative techniques are described briefly. Harvested vein grafts were gently distended with heparinized autologous blood under general anesthesia. The proximal anastomosis was completed first, and all distal anastomoses were performed under tourniquet ischemia without vascular clamps. Native arteries were dissected and only the anterior surface of the vascular sheath was exposed. During the anastomosis procedure, activated coagulation time was maintained around 200 seconds by administration of unfractionated heparin. After bypass surgery, all patients received continuous unfractionated heparin intravenously (10,000 or 12,000 U/day) for the first 24 hours. Thereafter, all patients regularly received oral antiplatelet agents (aspirin and ticlopidine).
Graft patency was confirmed by color Doppler echography. When graft occlusion was suspected, patients underwent angiography. Limb salvage was defined as preservation of enough of the foot to allow ambulation and included feet requiring a toe, or ray (finger amputation), or transmetatarsal amputation after bypass surgery. Patients receiving Syme's amputation, or below-or above-knee amputation were included in the limb loss criteria. Patients were followed at 1to 3-month intervals after discharge.
All patients, with severe or persistent rest pain received counseling regarding the options of attempted limb salvage or amputation and were allowed to make informed choices regarding the direction of care. The Ethics Committee of Tokyo University Hospital approved the surgery.
RESULTS
The underlying type of scleroderma comprised progressive systemic scleroderma in 6 patients and CREST syndrome in 2. Demographic characteristics of the population are shown in Table I . Seven patients were female and 1 was male, with a mean age of 68 Ϯ 10 years. The mean disease duration from time of diagnosis was 13 months (median, 10 months). Two of 8 patients had received long-term steroid treatment. The mean follow-up period after surgery (bypass or amputation) was 46 months (2-201 months, median, 33 months).
Preoperative data are shown in Table II . Skin perfusion pressure (SPP) was very low near the area of gangrene. ANCAs are antibodies against molecules playing a central role in neutrophil and markers of vasculitis related to neutrophil (the antigen of p-ANCA and c-ANCA is myeloperoxidase and proteinase 3, respectively). Activated neutrophils bound with ANCAs cause endothelial cell damage in vessels. Significant ANCA positivity (p-ANCA or c-ANCA) was not observed in any patient during the development of foot lesions. Antiphospholipid antibody is associated with thrombosis in collagen disease patients. However, only patient 7 was antiphospholipid antibody positive. She de-veloped acute thrombosis of the popliteal artery, and eventually underwent above-knee amputation because of acute necrosis of the lower leg with concomitant infection. All patients were ANA-positive and 6 had a high titer of ANA with centromere pattern before surgery. Interestingly, clinical symptoms other than foot lesions did not worsen in any patient, while they showed a constantly high titer of ANA with centromere pattern, which may reflect organ impairment due to scleroderma. Although 5 of 6 patients underwent regular tests for lung surfactant protein D (SP-D) and sialylated carbohydrate antigen (KL-6), markers of respiratory status in scleroderma, no positive test was observed during the follow-up of foot lesions (Table II) . These results suggest that a high titer of ANA (centromere pattern) may relate to the development of foot ulcers or gangrene in scleroderma. Fig 1, A shows the preoperative angiogram of patient 1, showing collaterals from the peroneal artery which collected the blood flow to the posterior artery at the ankle level. Preoperative angiography in patient 2 revealed an almost normal popliteal artery, whereas both the anterior and posterior tibial arteries were occluded proximally, and the peroneal artery was disrupted in the middle (Fig 1, B) . All patients had occlusions in the anterior and posterior tibial arteries and the peroneal artery.
Although all 8 patients were scheduled to undergo revascularization, only 6 patients (patient 1 to 6) underwent bypass surgery and the other 2 (patients 7 and 8) underwent primary lower limb amputation (Table III) . The reasons for primary amputation were lack of an appropriate autogenous vein and concomitant lower leg infection, respectively. Eventually, necrosis with infection extended above the ankle in both patients. Five patients underwent pedal artery bypass and 1 received distal peroneal artery bypass, using reversed autonomous great saphenous vein. The inflow artery was the distal popliteal artery in 5 patients and superficial femoral artery in 1 patient. The targeted artery was the posterior tibial artery at the ankle level in 2 patients, the common plantar artery in 1 patient, the peroneal artery in 1 patient and the dorsalis pedis artery in 2 patients. Patient 1 underwent sequential bypass from the popliteal to the peroneal to the posterior tibial artery.
The results of surgery are also listed in Table III . None of the patients died from surgical complication in the perioperative period. However, 1 patient who underwent primary above-knee amputation because of sepsis, could not overcome sepsis and died 2 months later (patient 7). None of the patients experienced major operative complications such as myocardial or brain infarction or pneumonia except 1 patient with wound infection (patient 6). One graft occluded 3 days after bypass and another four grafts failed within 2 years, while the other graft is still patent 6 months after surgery. During the follow-up period, a duplex echography scan detected a failing graft in 3 patients (patients 1, 2, and 4 in Table III ). We performed an endovascular intervention in 1 patient, but the graft occluded 1 month after percutaneous transluminal angioplasty (PTA) (patient 2). Patient 4, with a failing graft, refused to undergo additional bypass or endovascular intervention. His graft occluded completely a couple of months later. Patient 1, with a sequential bypass, who had stenosis at the sequential anastomosis, underwent additional bypass surgery from the distal popliteal to the graft. Then, a stenosis of the distal (arrowhead) anastomosis at the first bypass developed again, leading to a complete graft occlusion 3 months later. In Fig 2, A, the angiogram of patient 1 shows sufficient blood flow without substantial intimal narrowing 1 month after the first bypass surgery. However, including a revision, the bypass graft resulted in total occlusion in the course of 17 months. Eventually, 5 out of 6 patients had graft occlusion within 1 and 1/2 years. Only patient 6 has a patent graft 6 months after bypass surgery. Table III shows the status of wound healing and limb salvage. Patient 3 with graft occlusion 3 days after bypass surgery underwent below-knee amputation without wound healing. Revascularization achieved ulcer healing and pain relief in the other 5 patients (patients 1, 2, 4, 5, and 6). All patients with graft occlusion after initial wound healing (patients 1, 2, 4, and 5) had a 'subcritical ischemic leg'. Patients 2 and 5 achieved wound healing with toe amputation during patency of the bypass graft followed by an ulcer-free course even after graft occlusion, whereas patients 1 and 4 developed a new ulcer or gangrene after graft failure. Of those, patient 1 had a severe ischemic leg with calf muscle necrosis and underwent above-knee amputation 8 months after the graft occlusion. On the other hand, patient 4 has not showed any sign of further deterioration of his new ulcer for over 8 months. He refused to undergo major amputation and dealt with the pain using NSAIDs. Four out of 8 patients, including 2 who underwent primary major limb amputation, lost their leg.
Histologic examinations revealed irregular fibrosis of the artery at the proximal anastomosis from the amputated limb of patient 1 (Fig 2, B and C) . Intimal thickening contained myxoid change, associated with accumulation of spotty macrophages and smooth muscle cells (Fig 2, D) . Moderate intimal thickening also caused narrowing of the arterial lumen at the distal anastomosis (Fig 2, E) .
DISCUSSION
Patients with systemic scleroderma are predisposed to developing a variety of leg ulcers and gangrene. Vasculitis and/or thrombosis of digital arteries due to scleroderma are involved in this painful complication. Deformity of fingers is thought to worsen local ischemia. However, Hafner et al 6 reported that patients with scleroderma exhibited multiple etiological features of ulcers including venous and arterial factors and that atherosclerosis of the superficial femoral artery worsens ulcers and gangrene. On the other hand, Hasegawa et al 2 reported that vascular occlusion frequently occur within digital arteries and sometimes extends to tibial arteries in patients with digital ulcers or gangrene. Dorevitch et al 3 reported cases of lower limb amputation secondary to large vessel involvement in scleroderma. The present study, therefore, focused on patients with an ischemic leg ulcer or gangrene due to infrapopliteal artery occlusion. Involvement of the tibial arteries can cause harder-to-cure CLI inevitably necessitating major amputation.
The etiological mechanism of tibial arterial lesions remains unclear. Herrick et al 7 reported that mild vasculitis occurred in some patients with digital ischemia requiring amputation. Goldberger et al 8 suggested those patients with vasculitis were associated with antiphospholipid antibody (APA), a major factor of thrombosis in collagen disease. On the other hand, positive ANCAs (p-ANCA or c-ANCA) appear to be involved in inflammation including local vasculitis. However, Hafner et al 6 did not detect positive ANCAs in their study. We also found negative APA and ANCAs in most patients. Moreover, histologic examination of skin biopsies demonstrated mild vasculitis, while amputation specimens revealed no or mild vasculitis (data not shown). This study, therefore, failed to demonstrate that tibial arterial occlusion resulted from vasculitis. Wigley et al 9 demonstrated that anti-centromere antibodies were related to digit loss in patients with scleroderma and that scleroderma patients with a positive anticentromere antibody had an increased risk of major peripheral vascular occlusive disease. Takahashi et al, 10 on the other hand, reported that non-scleroderma patients with anti-centromere antibodies suffered toe gangrene with scleroderma-like vascular damage, and suggested that anticentromere antibodies may cause vascular damage. The present study showed strongly positive ANA with a centromere pattern, which recognized almost the same antigen as anti-centromere antibody. This strong antibody positivity may relate to vascular damage below the knee.
Revascularization in scleroderma patients with CLI may be associated with two problems. First, systemic scleroderma is known to extend to occlusion of digital vessels. Guiducci et al 11 reported that scleroderma is characterized by injury of the vascular wall and extensive damage of microvessels, suggesting that revascularization does not provide functional blood flow to ischemic tissue. Second, Herrick et al 7 found severe hyperplasia at sites of thrombosis in scleroderma, suggesting that hyperactivity of local cells lead to intimal thickening at anastomotic sites. The former causes graft failure a few days after surgery and the latter causes graft failure several months after surgery.
We experienced 1 patient with graft failure 3 days after surgery and 4 patients with graft failure several months after surgery, which resulted from extensive peripheral vessel occlusion and intimal thickening at the anastomotic site, respectively. The graft patency in this study contrasted with that in patients with bypass surgery for Fontaine IV atherosclerosis as we previous reported. 12 Fifty-seven (65 limbs) Fontaine IV atherosclerosis patients underwent bypass surgery to an ankle artery from 1991 to 2000; primary patency was 83%, and secondary patency was 93% at 2 years in those patients. 12 We applied the same criteria to patients in this study as well as patients with atherosclerosis based on the preoperative arteriogram. Although we recognized a patent tibial artery which was confirmed by preoperative angiography and targeted it in this study, like we did in patients with atherosclerosis, it was difficult to determine whether the targeted artery had enough run-off in scleroderma patients who may have extensive lesions in the digital arteries. In addition to the targeted artery with less inflammation, we confirmed that a patient should have a sufficient length of autogenous saphenous vein without infection around the ankle. When patients had tissue loss and needed Lisfranc' or higher amputation, we advised them to undergo a primary amputation as opposed to a bypass. On the other hand, this study showed that five of six cases of revascularization resulted in initial ulcer healing. In spite of poor long-term results of revascularization, even a temporary increase in circulation at the ulcer by revascularization may relieve pain and heal a refractory ulcer. In this study, the rate of deterioration of lower limb circulation appeared to have been accelerating for some time. When this rapid deterioration of lower limb circulation was halted by bypass with healing of amputated toes, patients might achieve stable circulation even if the graft became occluded.
Dorevitch et al 3 reported that 5 of 9 scleroderma patients, who had symptomatic peripheral vascular disease, came to lower limb amputation. Therefore, revascularization together with careful foot management may be the treatment of choice for scleroderma patients with CLI before major amputation.
Whatever the status of ulceration or gangrene, prevention of skin breakdown is most important. Because tissue has poor blood flow, minor skin trauma or spontaneous fissuring may progress to CLI. Bosentan, 13 an antagonist of the endothelin receptor, may be effective in prevention of new ulcers in patients with scleroderma. The upper 6 patients underwent revascularization surgery, while the lower 2 underwent primary limb amputation. Both the inflow and a targeted artery are described in Bypass Surgery.
Pop, Below-knee popliteal artery; SF, superficial femoral artery; Per, peroneal artery; Tp, posterior tibial artery at the ankle; DP, dorsalis pedis artery; PL, common plantar artery; O, successful limb salvage; X, major limb loss; ⌬, patient 4 with persistent foot ulcer; Pt. no., patient number; PSS, progressive systemic scleroderma; BK, below the knee.
In conclusion, patients with systemic scleroderma who develop CLI due to tibial artery occlusions have high rates of limb loss. Because compromised skin integrity associated with this connective tissue disorder predisposes patients to ulcerations, comprehensive foot protection and care is a critical part of any limb salvage attempt. Although tibial level arterial reconstruction (ie, distal bypass) results in pain relief and early wound healing, even meaningful patency and limb salvage rates are poor.
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